Oxford/AstraZeneca vaccine: rare blood clot syndrome has high mortality rate

Oxford/AstraZeneca vaccine: rare blood clot syndrome has high mortality rate

Researchers found that clots occurring after first dose of Oxford jab affected otherwise young and healthy people

0
Like
Save